Delivery Order SPE2DB20D3101-SPE2DB25FRNT0
- Not listed
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,142,269 units of the diabetes medication Liraglutide 2-Pak 18 mg/3 ml 3 ml. The contract is a firm fixed-price delivery order with a ceiling value of $1,320.00 and a performance period extending through May 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation,...
- This is a $8,722.36 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a diabetes medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA, which provides comprehensive global pharmaceutical support to military healthcare programs. The contract is not...
- This federal contract award, valued at $26,405.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product used in the treatment of diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,501.82, is for the delivery of Liraglutide 2-pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 21, 2025. The contract does not have a set-aside designation, indicating open...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Liraglutide 3-pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The award has a ceiling value of $1,835.04 and a completion date of July 7, 2025. This is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,505.45, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3ml, a diabetes medication. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,581.38 firm fixed-price delivery order is for the supply of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a diabetes treatment medication. The contract has an ultimate completion date of May 14, 2025 and was awarded on May 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,618.80, is for the delivery of Liraglutide 2-pak 18 mg/3 ml 3 ml, a diabetes treatment medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. The award...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,069.26 contract is for the delivery of 4568495958 - LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a diabetes medication. The order has a completion date of June 10, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,405.49, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRNT0Delivery Order
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Liraglutide 2-Pak 18 mg/3 ml 3 ml, a diabetes medication, with a ceiling value of $1,210.18. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp, as the prime contractor, will be responsible for supplying the requested pharmaceutical product to support military and government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/26/25 |